Introduction
Patients suffering from chronic pain with no identifiable organic cause (somatoform pain disorder) tend to be resistant to treatment and visit a number of medical institutions ("doctor shopping") 17) Chronic lower back and leg pain are the most frequent com- 
Summary
The efficacy of the tricyclic antidepressant amoxapine was investigated in 20 subjects suffering from somatoform pain disorder consisting of chronic lower back and leg pain with no identifiable organic cause and resistant to treatment Evaluation of efficacy was made both prior to and 6 months after administration using the visual analogue scale (VAS) and self-rating depression scale (SDS) VAS and SDS improved significantly after amoxapine administration If a VAS improvement rate ≥ 50% is defined as effective and < 50% as ineffective then there were 10 subjects where the treatment could be rated as effective and 10 as ineffective Correlations between pain response to amoxapine and subject background factors were consequently examined but no predictive factors could be identified The onset of the effect was 1 week in 7 subjects and after 2 3 and 4 weeks in 1 subject respectively The strongest effect tended to be shown in those subjects where the onset was earliest These results indicate amoxapine administration may be an intervention worthy of consideration in cases of lower back and leg pain with no identifiable organic cause and resistant to other forms of treatment and that the efficacy can be evaluated in relatively short period of time the tricyclic class of agents (TCA) have been Table 2 The subjects com- (1) or (2):
Materials and Methods
(1) appropriate evaluation uncovers no organic pathology or pathophysiologic mechanism (e.g., a physical disorder or the effects of injury) to account for the pain (2) and psychological factors by the Ransford score (RS) using pain drawings 19) For the VAS a 100 mm horizontal scale was used with a score in the left margin (a score of 0) representing no pain and to the far right (a score of 100) the worst pain imagin- The relationship between pain and degree of depression (N=20)
The correlation was evaluated using the rate of improvement from the baseline (pre-treatment score) as calculated from the VAS and SDS scores prior to administration and 6 months following administration A moderate correlation (r=0 58) was observed between the rate of improvement in VAS and SDS However results tended to be polarized into one group with markedly improved VAS scores and another group with little improvement including some cases of further deterioration 74 17) (Figure 2 The timing of the onset of effect (≥ 50% VAS improvement rate) was 1 week in 7 subjects and after 2 3 and 4 weeks in 1 subject respectively with a tendency for a strong effect being shown in those subjects in whom the onset was earliest Efficacy was sustained in these subjects throughout the peri- 
